Sleep Number (SNBR) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
12 Mar, 2026Executive summary
2025 marked a pivotal turnaround year, with a reshaped team driving operational and strategic changes across all business areas.
Achieved $185 million in annualized cost savings and launched new products, including the ComfortMode bed, which outperformed expectations with 3.5x planned sales and stronger margins.
Delivered on prior guidance for net sales and exceeded adjusted EBITDA expectations, despite a challenging industry environment.
Full-year net loss was $132 million, compared to a $20 million loss last year, mainly due to lower sales and a deferred tax valuation adjustment.
Significant cost reductions and a leaner organization established a foundation for future growth.
Financial highlights
Full year net sales were $1.41 billion, down 16% year-over-year but in line with guidance.
Adjusted EBITDA reached $78 million, surpassing the $70 million outlook, with a full-year margin of 5.5%.
Q4 net sales were $347 million, 8% below the prior year, with sequential improvement throughout the year.
Q4 gross profit margin was 55.6%, down 430 bps due to a $9.6 million non-recurring inventory charge; adjusted margin was 58.4%.
Full-year net loss was $132 million, with Q4 net loss at $59 million.
Outlook and guidance
No formal 2026 guidance provided due to ongoing transformation, but expectations are for sequential revenue improvement and positive free cash flow.
Q1 2026 net sales expected to decline in the high teens percent, with significant improvement in Q2 as new products launch.
Double-digit sales and adjusted EBITDA growth anticipated in the second half of 2026, driven by new products and marketing initiatives.
Implementing an additional $50 million in annualized fixed cost savings in 2026.
Latest events from Sleep Number
- Proxy seeks board declassification, equity plan expansion, and governance modernization.SNBR
Proxy filing24 Mar 2026 - Turnaround strategy and cost reductions set the stage for growth and free cash flow in 2026.SNBR
Investor presentation12 Mar 2026 - Gross margin and cost improvements offset sales declines, supporting full-year EBITDA guidance.SNBR
Q2 20242 Feb 2026 - Gross margin hit a three-year high as cost cuts offset a 10% sales decline in Q3.SNBR
Q3 202417 Jan 2026 - Major transformation underway with cost cuts, new products, and a focus on value-driven growth.SNBR
28th Annual ICR Conference 202613 Jan 2026 - Transformation plan targets growth, efficiency, and strong free cash flow in 2026.SNBR
Investor presentation13 Jan 2026 - Gross margin gains and cost cuts drove Q4 EBITDA up 43% despite double-digit sales declines.SNBR
Q4 202425 Dec 2025 - Q1 2025 sales dropped 16% with a $8.6–$9M net loss, but gross margin rose to 61.2%.SNBR
Q1 202523 Dec 2025 - Board proposes governance reforms, new CEO, and equity plan changes amid industry headwinds.SNBR
Proxy Filing1 Dec 2025